Author: Newsdesk

In the news release, The Sotheby’s International Realty Brand Expands in Oregon, issued 26-Jan-2026 by Sotheby’s International Realty over PR Newswire, we are advised by the company that the boilerplate second paragraph, second sentence, should read “Both entities are subsidiaries of Compass International Holdings (NYSE: COMP), a global real estate services company with a presence in every major U.S. city and in approximately 120 countries and territories.” The complete, corrected release follows:

The Sotheby’s International Realty Brand Expands in Oregon

NEW YORK, Jan. 26, 2026 /PRNewswire/ — Sotheby’s International Realty Affiliates LLC has announced that Town & Country Realty located in Corvallis, Oregon is joining the network, and its office will now operate as Town & Country Sotheby’s International Realty. This addition signifies the brand’s continued growth in Oregon with 20 offices in the state.

The Mid-Willamette Valley is home to two State Universities and is the state’s primary wine region known for Pinot Noir, Chardonnay, and Pinot Gris. The luxury real estate market is defined by lifestyle-driven properties that emphasize space, privacy, and quality construction. Luxury offerings include custom-designed homes, riverfront properties, vineyard-adjacent estates, and significant acreage. The region’s temperate climate, scenic landscapes, with easy access to the Oregon Coast, Cascade and Coast mountain ranges, rivers, and trails make it especially appealing to outdoor enthusiasts and buyers seeking a balanced, livable lifestyle.

Town & Country Sotheby’s International Realty is led by Lisa Marie Boyd, whose background brings a thoughtful, analytical perspective to real estate. She has 16 years of real estate experience, having obtained her license in 2010, and has served as the owner of Town & Country Realty since 2016, guiding the firm with vision and dedication. Boyd served as the President of the Willamette Association of REALTORS^® (WAOR) and was recognized as its REALTOR of the Year in 2025 by the Willamette Association of Realtors, reflecting her leadership and commitment to professional excellence.

“Corvallis, Oregon, is a beautiful college town known for its stunning surroundings, outdoor recreation, and its competitive real estate market. The Sotheby’s International Realty brand has had a strong presence in Oregon for many years, and we are excited to welcome the 20^th office in the state to continue to bring prime real estate to the buyers and sellers in the region,” said Philip White, president and CEO, Sotheby’s International Realty. “We look forward to supporting Town & Country Sotheby’s International Realty as we continue to expand the brand’s presence in Oregon.” 

“The Sotheby’s International Realty brand is the leader in luxury real estate, and with its unparalleled global reach, we believe this network is most beneficial to our clients and affiliated agents,” said Lisa Marie Boyd, Managing Principal Broker/Owner. She added, “For 75 years, Town & Country Realty has been proud to serve our community as local real estate experts. Now, as part of the Sotheby’s International Realty network, we’re your local experts with global reach–offering exceptional service at every price point, locally and worldwide.”

The Sotheby’s International Realty® network currently has more than 21,600 affiliated independent sales associates located in 1,100 offices in 86 countries and territories worldwide. Sotheby’s International Realty listings are marketed on the sothebysrealty.com global website. In addition to the referral opportunities and widened exposure generated from this source, the firm’s brokers and clients will benefit from an association with Sotheby’s auction house and worldwide Sotheby’s International Realty marketing programs. Each office is independently owned and operated. 

Sotheby’s International Realty
Sotheby’s International Realty was founded in 1976 as a real estate service for discerning clients of Sotheby’s. Today, the company’s global footprint spans more than 1,100 offices located in 86 countries and territories worldwide, including 47 company-owned brokerage offices in key metropolitan and resort markets.  Through a long-term strategic alliance with Sotheby’s, one of the world’s premier destinations for art and luxury, the company licenses the Sotheby’s International Realty brand for its franchise system. The franchise system is comprised of an affiliate network, where each office is independently owned and operated. Sotheby’s International Realty supports its affiliates and agents with a host of operational, marketing, recruiting, educational and business development resources. Affiliates and agents also benefit from an association with Sotheby’s, established in 1744. For more information, visit www.sothebysrealty.com. 

The affiliate network is operated by Sotheby’s International Realty Affiliates LLC, and the company owned brokerages are operated by Sotheby’s International Realty, Inc. Both entities are subsidiaries of Compass International Holdings (NYSE: COMP), a global real estate services company with a presence in every major U.S. city and in approximately 120 countries and territories. Both Sotheby’s International Realty Affiliates LLC and Sotheby’s International Realty, Inc. fully support the principles of the Fair Housing Act and the Equal Opportunity Act. 

Contact 
Kristina Helb
Vice President of Global Communications
[email protected]  

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-sothebys-international-realty-brand-expands-in-oregon-302670046.html

SOURCE Sotheby’s International Realty

Issued on behalf of VisionWave Holdings, Inc.

VANCOUVER, BC, Jan. 26, 2026 /PRNewswire/ — USA News Group News Commentary – Global defense expenditure reached an unprecedented $2.718 trillion in 2024, marking the steepest year-over-year rise since the Cold War as NATO members alone deployed $1.506 trillion to accelerate structural consolidation across autonomous weapons platforms and aerospace aftermarket networks^[1]. The artificial intelligence defense market is projected to expand to $22.75 billion by 2029, driven by developments in autonomous weapon systems and high-velocity decision logic that collapse threat evaluation timelines from minutes into microseconds^[2]. This convergence positions VisionWave Holdings Inc. (NASDAQ: VWAV), Boeing (NYSE: BA), TransDigm Group (NYSE: TDG), Booz Allen Hamilton (NYSE: BAH), and BAE Systems (OTCPK: BAESY) as specialized engineering nodes across the defense modernization supercycle.

Aerospace and defense analysts forecast aftermarket MRO demand will expand at a 3.2% CAGR through 2035, with US defense AI spending projected to reach $5.8 billion by 2029 as operators prioritize integrated mission systems and engine sustainment contracts^[3]. The Department of Defense’s $961.6 billion FY2026 budget request and the proposed $175 billion Golden Dome space-based missile defense architecture underscore how layered defensive systems and proprietary command-control intellectual property now establish the primary valuation floor for defense primes navigating the strategic M&A landscape^[4].

VisionWave Holdings Inc. (NASDAQ: VWAV) is building a comprehensive autonomy platform that combines advanced radio-frequency sensing, computational acceleration, and industrial robotics across defense and critical energy infrastructure markets worldwide.

The company recently acquired qSpeed, a proprietary computational acceleration engine independently valued at $99.6 million by BDO Consulting Group. This technology addresses a fundamental challenge in modern defense systems: the decision latency that exists between threat detection and response execution. In battlefield scenarios where microseconds determine outcomes, qSpeed is designed to eliminate computational bottlenecks that traditionally slow threat assessment and targeting processes.

VisionWave has announced initial progress integrating qSpeed across multiple operational platforms, including WaveStrike™ RF-enabled fire control systems and Argus™ counter-drone technology. The system works by prioritizing decision-critical computations first, enabling rapid initial conclusions that continuously refine themselves as additional data becomes available. This intelligent approach compresses threat evaluation timelines from minutes into seconds without requiring operators to replace existing hardware infrastructure, reducing both cost and deployment friction.

For WaveStrike specifically, qSpeed integration delivers RF-informed, operator-assisted targeting capabilities by collapsing computation cycles required for range estimation and lead calculation. The result is instantaneous targeting guidance during high-velocity engagement scenarios, providing human operators with real-time firing solutions when they need them most.

VisionWave’s intellectual property position strengthened significantly with the issuance of U.S. Patent No. 12,499,578, which secures enforceable protection for the proprietary radio-frequency sensing and artificial intelligence architecture powering both Argus and its SkyWeave high-frequency communications backbone. This patent establishes defensible market positioning in the rapidly growing space-enabled counter-UAS sector.

Beyond defense applications, VisionWave is executing a strategic expansion into Southern Europe through its Solar Drone Ltd. subsidiary. The company has secured follow-on hardware orders and established distribution agreements covering Italy and Spain, targeting critical infrastructure maintenance markets across the region.

VisionWave’s universal Adaptation Kit enables seamless integration of heavy-duty payloads exceeding 200 pounds into any third-party drone fleet. This drone-agnostic approach allows infrastructure operators to deploy VisionWave technology for high-voltage insulator cleaning and power grid maintenance without replacing their existing equipment investments.

To accelerate commercialization timelines, VisionWave plans to invest up to $10 million in U.S.-based development over the next 6 to 12 months, pushing qSpeed toward production readiness while simultaneously expanding its addressable market across defense and energy infrastructure sectors.

CONTINUED… Read this and more news for VisionWave Holdings at:
  https://usanewsgroup.com/2025/09/11/the-ai-defense-technology-developments-potentially-relevant-in-2025-26/

Boeing (NYSE: BA) and the Royal Australian Air Force have successfully executed a force integrated air-to-air autonomous weapon engagement from an MQ-28 Collaborative Combat Aircraft. The landmark mission involved an MQ-28 Ghost Bat teaming with a RAAF E-7A Wedgetail and F/A-18F Super Hornet to destroy a fighter-class target drone using a Raytheon AIM-120 AMRAAM missile, marking the first time an autonomous aircraft has completed an air-to-air weapon engagement.

“This is the first time an autonomous aircraft has completed an air-to-air weapon engagement with an AIM-120 missile, establishing the MQ-28 as a mature combat capable CCA,” said Amy List, managing director of Boeing Defence Australia. “This latest achievement proves the advantage specialized CCA platforms bring to defense forces’ mission effectiveness, delivering increased operational mass and data exchange for informed decision-making while reducing cost and crewed pilot risk.”

The mission demonstrated sophisticated crewed-uncrewed teaming with the E-7A operator maintaining custodianship of the MQ-28 while the F/A-18F provided sensor coverage and shared targeting data across all three platforms. Boeing implemented open architectures and an advanced digital ecosystem to develop the necessary hardware, software and mission systems in under eight months.

TransDigm Group (NYSE: TDG) has entered into a definitive agreement to acquire Jet Parts Engineering and Victor Sierra Aviation Holdings for approximately $2.2 billion in cash including certain tax benefits. The companies are leading independent designers and manufacturers of proprietary PMA and OEM-alternative aerospace aftermarket parts, collectively generating approximately $280 million in revenue for calendar year 2025 with nearly 100% commercial aftermarket revenue across commercial airlines, business aviation and general aviation sectors.

“We are excited to have an agreement to acquire Jet Parts Engineering and Victor Sierra, two well run, profitable businesses that will fit well within TransDigm,” said Mike Lisman, CEO of TransDigm. “The Companies’ highly engineered, proprietary OEM-alternative parts and services generate nearly 100% commercial aftermarket revenue.”

JPE serves commercial, regional and cargo airlines with proprietary PMA components across major commercial aerospace platforms from facilities in Washington, Texas, New York, Florida, Alabama and the United Kingdom with approximately 300 employees. VSA offers a complete line of highly engineered PMA, custom design and OEM products through brands including McFarlane Aviation, Tempest Aero Group and Aviation Products Systems from facilities in Kansas, North Carolina and Illinois with approximately 400 employees.

Booz Allen Hamilton (NYSE: BAH) has announced a new collaboration with Andreessen Horowitz to strengthen America’s technical supremacy. As the first-ever a16z Technology Acceleration Partner for Governments, Booz Allen will work with companies across the a16z portfolio to build, accelerate and deliver technologies for U.S. missions in national security, civilian services and beyond, leveraging deep mission expertise, strategic networks and leading capabilities in AI, cybersecurity, warfare tech and engineering.

“a16z and Booz Allen have a strong history working with world-class startups to successfully deliver commercial technologies into U.S. missions,” said Horacio Rozanski, Chairman and CEO of Booz Allen. “Now we are combining the full capacity of a16z’s preeminent VC network and Booz Allen’s proven ability to build advanced tech and accelerate its adoption to drive America’s tech supremacy.”

The partnership aims to help growth-stage companies in the a16z portfolio go faster to market, prepare products for deployment into secure networks and highly regulated government environments, and co-develop IP for new commercial offerings. Booz Allen employs approximately 32,500 people globally as of September 30, 2025 and had revenue of $12.0 billion for the 12 months ended March 31, 2025.

BAE Systems (OTCPK: BAESY) has received a £453.5 million contract from the UK Ministry of Defence for full production of the ECRS Mk2 advanced radar for UK Typhoon aircraft. The state-of-the-art radar delivers enhanced electronic warfare capability, allowing the aircraft to detect, identify and track multiple targets in the air and on the ground, with the funding directly supporting 1,300 jobs across UK industry in advanced radar development and integration including 400 jobs at Leonardo and more than 120 jobs at BAE Systems predominantly in Scotland and North West England.

“The Typhoon programme is a fundamental pillar of the UK’s national defence and security,” said Richard Hamilton, Managing Director – Air Operations at BAE Systems Air. “The continued investment in Typhoon capability is crucial and ensures we’re able to maximise the UK’s investment in the aircraft and accelerate combat air technologies critical for defence capabilities.”

BAE Systems and Leonardo UK will lead delivery of 38 ECRS Mk2 radars integrated onto the full fleet of Tranche 3 standard jets with the radar due to enter service with the RAF by the end of the decade. The Typhoon programme supports more than 20,000 jobs throughout the UK annually and has delivered in excess of £30 billion of export value to the UK economy.

Article Sources:

https://usanewsgroup.com/2025/09/11/the-ai-defense-technology-developments-potentially-relevant-in-2025-26/ 

CONTACT:

USA NEWS GROUP


[email protected]


(604) 265-2873

DISCLAIMER:
Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA News Group is owned by Market IQ Media Group, Inc. (“MIQ”). This article is being distributed for MIQ, who has been paid a fee for VisionWave Holdings, Inc. advertising and digital media from the company directly. There may be 3rd parties who may have securities of VisionWave Holdings, Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ owns securities of VisionWave Holdings, Inc. which were purchased in the open market. MIQ reserves the right to buy and sell, and will buy and sell shares of VisionWave Holdings, Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material, including this article, which is disseminated by MIQ has been approved by VisionWave Holdings, Inc.; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.  This publication may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and beliefs and involve risks and uncertainties that could cause actual results to differ materially from those described.  Forward-looking statements in this document are subject to risks and uncertainties, including technological, regulatory, market, and geopolitical factors, which may cause actual results to differ materially. VisionWave Holdings, Inc. makes no representations or warranties as to the accuracy of third-party projections or market data cited herein.  For more information on risks, see VisionWave Holdings Inc.’s filings with the SEC.

SOURCES:

1.   https://editorialge.com/global-defense-inflation/
2.   https://www.globenewswire.com/news-release/2026/01/07/3214699/28124/en/Artificial-Intelligence-in-Defense-and-Security-Global-Research-Report-2025-Market-to-Reach-22-75-Billion-by-2029-Long-term-Forecast-to-2034.html
3.   https://www.deloitte.com/us/en/insights/industry/aerospace-defense/aerospace-and-defense-industry-outlook.html
4.   https://www.psware.com/2026-aerospace-and-defense-industry-outlook/ 

 

Logo – https://mma.prnewswire.com/media/2838876/5734905/USA_News_Group_Logo.jpg

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-apex-defender-why-strategic-ma-and-autonomous-tech-are-driving-a-2-7t-valuation-302670126.html

In the news release, Next-Generation RF Systems Move to the Center of Global Defense Spending, issued 26-Jan-2026 by Market News Updates over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end:

Next-Generation RF Systems Move to the Center of Global Defense Spending

AI-driven RF platforms are transforming how militaries detect, disrupt, and dominate threats across land, air, sea, and space

NEW YORK, Jan. 26, 2026 /PRNewswire/ — Market News UpdatesNews Commentary – Next-generation RF-based defense and security technology is quickly becoming one of the most important building blocks of modern military systems. From advanced radar and electronic warfare to secure communications, spectrum monitoring, and counter-drone solutions, RF technology sits at the center of how today’s defense forces detect threats, stay connected, and control the battlespace. What’s changing now is intelligence and flexibility—AI-driven signal processing, software-defined radios, and adaptive spectrum technologies are making RF systems faster, smarter, and far more resilient against jamming, spoofing, and electronic attacks. In short, whoever controls the spectrum increasingly controls the mission. Active Companies in the defense space to keep a close eye on include: VisionWave Holdings Inc. (NASDAQ: VWAV), RTX Corporation (NYSE: RTX), AeroVironment Inc (NASDAQ: AVAV), Leidos (NYSE: LDOS), Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS).

From an investor standpoint, the market momentum behind RF-based defense systems is hard to ignore. The broader RF technology market—which includes components, sensors, and integrated systems used heavily in defense and security—is expected to see strong, sustained growth over the next decade as global defense budgets prioritize electronic warfare, ISR, and counter-UAS capabilities. Analysts estimate the RF components market alone could exceed $90 billion by the early 2030s, with defense applications representing a meaningful and growing share. Add in specialized military RF chips, tactical communications, and sensor platforms, and the addressable market continues to expand as modernization programs accelerate worldwide.

For investors, RF-based defense technology offers a compelling mix of long-term government demand and near-term innovation upside. Defense contracts tend to be sticky and multi-year, providing revenue visibility, while rapid advances in AI, semiconductors, and spectrum technologies create opportunities for emerging players to scale quickly or become acquisition targets. As geopolitical tensions persist and electronic warfare becomes a top strategic priority, companies that deliver smarter, more adaptive RF solutions are well positioned to benefit. This makes next-generation RF technology not just a defense necessity—but a growing investment theme with durable tailwinds.

VisionWave (NASDAQ: VWAV) and SaverOne Announce Execution of Strategic Exchange Agreement to Establish RF-Based Defense Platform –
VisionWave Holdings Inc. ($VWAV) (“VisionWave” or the “Company”) and SaverOne 2014 Ltd. (Nasdaq: SVRE) (“SaverOne”) today jointly announced that they have entered into a definitive strategic Exchange Agreement to develop an RF-based defense and security technology platform.

The transaction includes $7.0 million in staged equity consideration payable to SaverOne, and is structured to provide for a three-stage equity exchange and strategic collaboration between the two companies.

Under the agreement, VisionWave may acquire approximately 51% of SaverOne on a fully diluted basis, subject to milestone achievement, regulatory approvals, and customary closing conditions. VisionWave will be authorized to appoint one director to SaverOne’s Board at the initial investment stage, and subject to meeting the specified development milestones, to appoint one additional director upon completion of each investment stage. SaverOne will serve as the core operating platform for specified RF-based defense and security applications, supported by a non-exclusive global license to VisionWave’s proprietary RF sensing and analytics technologies for defense and homeland-security use.

Immediate Expansion of VRU Platform –
VisionWave and SaverOne intend to integrate VisionWave’s RF Technologies into SaverOne’s existing VRU (Vulnerable Road User) platform, integrating RF sensing and AI-driven analytics designed to address concealed, obscured, and non-line-of-sight threats.

Management currently estimates that an RF-enhanced, commercially deployable solution addressing identified concealed-threat scenarios could be demonstrated during the 2026 calendar year, subject to continued development, testing, and validation. The expanded platform is intended to assist in environments where optical and LiDAR-only sensing systems face inherent limitations, including occlusion, cluttered terrain, adverse weather, and complex infrastructure settings.

Unified RF Defense and Security Platform –
The strategic collaboration seeks to develop an RF defense platform combining VisionWave’s RF sensing, imaging, and AI-based decision technologies with SaverOne’s established engineering, system integration, and commercialization capabilities.

The platform is aiming to support a range of defense and security applications, including:

• Detection of concealed or obscured threats
• Counter-UAS and drone sensing
• Perimeter and infrastructure protection
• Battlefield and tactical situational awareness
• RF-based threat classification in complex environments

The goal of the platform is intended to complement existing sensing architectures and support deployment across military, homeland-security, and critical-infrastructure environments, subject to technical feasibility and applicable regulations.

Governance and Board Approval
  – The transaction was unanimously approved by both VisionWave’s and SaverOne’s Boards of Directors following receipt and consideration of an independent fairness opinion and valuation analysis from BDO Consulting Group, which concluded that the transaction is fair, from a financial point of view, to VisionWave, SaverOne and their stockholders. The entire transaction is subject to the approval of SaverOne’s shareholders.

Leadership Commentary –
“This transaction is designed to develop a focused RF defense platform with the goal of operating where traditional sensing technologies reach their limits,” said Douglas Davis, Executive Chairman of VisionWave Holdings. “By integrating RF capabilities into SaverOne’s VRU platform, we believe the collaboration may result in solutions addressing threats that are currently hidden from view.”

Ori Gilboa SaverOne’s CEO added, “The agreement positions SaverOne as the operational center for a scalable RF-based defense platform, combining engineering infrastructure with VisionWave’s sensing technologies to address evolving security challenges.”  Continued… Read this full release and additional news for VWAV by visiting: https://finance.yahoo.com/quote/VWAV/news/

Other recent developments in the tech/military/defense industries include:

Collins Aerospace, an RTX Corporation (NYSE: RTX) business, has entered into three-year parts distribution agreements with Integrated Procurement Technologies, S3 AeroDefense and Derco, a Lockheed Martin company, to enhance hardware and logistics support for wheels and brakes on the C-130 Hercules.

By expanding its network of distribution partners, Collins Aerospace ensures targeted support for C-130 operators throughout the hardware lifecycle. This benefits international customers currently flying the C-130 with Collins wheels and brakes, as well as those considering upgrading their fleet.

“The C-130 Hercules plays a vital role in global air mobility, supporting everything from combat operations to humanitarian relief,” said Matt Maurer, Vice President and General Manager of Landing Systems at Collins Aerospace. “Wheels and brakes are mission-critical components for the aircraft, enabling safe takeoffs, landings and ground operations on some of the world’s most challenging runways. These distribution agreements will help ensure fleet readiness for our customers, enabling them to operate where they’re needed most.”

Parry Labs, a defense technology company delivering modular open systems and edge infrastructure for the modern battlespace, is partnering with AeroVironment Inc (NASDAQ: AVAV) to architect, develop, deliver, and integrate Modular Open Systems Approach (MOSA)-aligned digital engineering, software, and mission system hardware for the newly developed P550™ Uncrewed Aircraft System (UAS) for the U.S. Army’s Long Range Reconnaissance (LRR) program.

As mission systems integrator, Parry Labs is embedding its proven mission system components into P550 to ensure the Army receives a platform that evolves with the mission and interoperates across the Family of Systems.

For this program, Parry Labs will provide expertise in Model-Based Systems Engineering (MBSE) development and open software operating environments to help AV implement the capabilities required by the LRR program and enable future integration of new capabilities.

Leidos (NYSE: LDOS) and OpenAI are partnering to deploy artificial intelligence in support of national priorities, including boosting the efficiency and effectiveness of government agencies.

The companies plan on integrating Open AI-powered generative and agentic AI into the core workflows of customers in strategic markets including digital modernization, health services, national security and infrastructure, and defense. Those are the foundations of Leidos’ NorthStar 2030 growth strategy.

“Leidos and OpenAI are harnessing the transformative power of AI to help improve how federal agencies operate,” said Leidos Chief Technology Officer Ted Tanner. “With OpenAI’s most powerful models in a secure configuration designed to protect Leidos and customer data, we’re working together to enhance productivity and accelerate product development and delivery.”

Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in defense, national security, and global markets, announced recently the grand opening of its new 55,000-square-foot state-of-the-art hypersonic and “Other” system manufacturing and payload integration facility in Princess Anne, Maryland.

The advanced facility will significantly enhance Kratos’ capabilities to support launch operations and hypersonic testing for the Multi-Service Advanced Capability Hypersonics Test Bed (MACH-TB) 2.0 program and other customers from agencies including the U.S. Navy, US Air Force, DARPA, and the Missile Defense Agency.

“This strategic investment in Princess Anne represents Kratos’ commitment to expanding our nation’s hypersonic testing infrastructure and capabilities,” said Dave Carter, President of Kratos Defense & Rocket Support Services Division. “The new facility enables us to increase production capacity, streamline payload integration processes, and respond even more rapidly to the growing demand for affordable hypersonic flight testing. The Princess Anne facility will play a crucial role in supporting our $1.4 billion MACH-TB 2.0 contract and other critical programs, enabling increased test cadence and more affordable flight test opportunities for hypersonic technologies.”

DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU’S market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This press release was distributed on behalf of VisionWave Holdings, Inc. For current services performed MNU was compensated forty nine hundred dollars for news coverage of the current press releases issued by VisionWave Holdings, Inc. by the Company. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.

Contact Information:

Media Contact email: [email protected]
+1(561)486-1799

Logo: https://mma.prnewswire.com/media/2852558/5733946/Market_News_Updates_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/next-generation-rf-systems-move-to-the-center-of-global-defense-spending-302669741.html

SOURCE Market News Updates

Issued on behalf of Avant Technologies Inc.

Equity Insider News Commentary

VANCOUVER, BC, Jan. 26, 2026 /PRNewswire/ — The medical world is shifting as the global market for next-gen treatments heads toward $88.85 billion by 2030^[1], driven by a surge in funding for high-tech cures for long-term illness. A major FDA move at the beginning of the year^[2] is now making it much easier to build these advanced platforms, clearing a path for companies that can treat diseases internally without the harsh side effects of traditional drugs. This regulatory shift positions Avant Technologies, Inc. (OTCQB: AVAI), MannKind (NASAQ: MNKD), Vertex Pharmaceuticals (NASDAQ: VRTX), Fate Therapeutics (NASDAQ: FATE), and Ardelyx (NADSAQ: ARDX) at the center of a massive transformation in chronic healthcare.

 

 

Smart investors are preparing for a major 2026 rebound as capital flows into the most innovative and results-driven medical platforms^[3]. With the total biotech sector projected to reach $9.06 trillion by 2035^[4], the biggest opportunities are in companies solving massive issues like diabetes and kidney disease with better clinical execution. In 2026, the market is favoring ‘ready-to-go’ platforms over early-stage speculation, rewarding the companies that have built the infrastructure to dominate the next generation of medicine.

Avant Technologies, Inc. (OTCQB: AVAI) is tackling some of healthcare’s biggest challenges with a novel approach: genetically modified cells that produce therapeutic proteins inside the body, protected by a proprietary shield that keeps the immune system from attacking them. The company operates through two joint ventures targeting markets worth hundreds of billions of dollars.

The core innovation is a cell encapsulation technology that solves a fundamental problem in regenerative medicine. When doctors transplant therapeutic cells into patients, the immune system typically destroys them within days or weeks. The traditional solution requires lifelong immunosuppressive drugs that cause serious side effects including infection risk, organ damage, and elevated cancer risk. Avant’s technology eliminates this problem by creating a protective barrier around the cells while still allowing nutrients, oxygen, and therapeutic proteins to pass through freely.

The first venture, Insulinova, Inc., partners with SGAustria Pte. Ltd. to develop treatments for type 1 diabetes and insulin-dependent type 2 diabetes. The approach uses genetically modified cells that produce, regulate and store insulin, essentially creating a bio artificial pancreas that restores natural glucose control without immunosuppressive drugs. The diabetes market opportunity is substantial: 589 million people globally live with type 1 and insulin-dependent type 2 diabetes, projected to reach 853 million by 2050 according to the International Diabetes Federation.

“Cell encapsulation is a game changer in the field of regenerative medicine,” said Chris Winter, CEO of Avant Technologies. “By partnering with SGAustria, we’re ensuring that genetically modified insulin-producing cells can thrive in the body long-term and offer the potential of restoring natural glucose control and dramatically improving patients’ quality of life. This technology not only minimizes risks like immune rejection but also prevents potential complications such as cell escape or tumor formation, making it a cornerstone for safe and scalable diabetes therapies.”

Avant’s second venture, Klothonova, partners with Singapore-based Austrianova to develop therapies for both age-related diseases and anti-aging therapies using cells that produce the Klotho protein. Research from the Mayo Clinic links declining Klotho levels to arterial stiffness, endothelial dysfunction, and vascular calcification.

Both platforms are backed by over 50 peer-reviewed publications representing decades of development. The addressable markets span multiple areas: Alzheimer’s disease ($32.8 billion by 2033), cardiovascular disease (32% of global deaths), and kidney disease (850 million affected worldwide).

The strategic advantage lies in platform versatility. The same encapsulation technology that protects insulin-producing cells can theoretically protect cells producing other therapeutic proteins, potentially opening pathways into additional disease indications. This positions Avant at the intersection of multiple high-value healthcare markets with a single core technology that addresses the immune rejection challenge across different applications.

CONTINUED… Read this and more news for Avant Technologies at:


https://equity-insider.com/2025/03/21/unlocking-the-trillion-dollar-ai-market-what-investors-need-to-know/ 

MannKind (NASDAQ: MNKD) provided business updates outlining anticipated growth drivers for 2026, including progress across commercial programs and clinical development initiatives following a record-setting fourth quarter surpassing $100 million in net revenue. The company expects two high-potential launches on the horizon with FDA decisions anticipated for Afrezza label updates and FUROSCIX ReadyFlow Autoinjector.

“MannKind closed 2025 on a high note, marked by milestones that reinforce our growth trajectory—including the acquisition of scPharmaceuticals and a record-setting fourth quarter surpassing $100 million in net revenue,” said Michael Castagna, PharmD, CEO of MannKind Corporation. “With two high-potential launches on the horizon, 2026 is shaping up to be a catalyst-rich year that positions MannKind for long-term value creation.”

Major catalysts include an FDA decision on Afrezza dose conversion with PDUFA date of January 23, 2026, and review of the supplemental BLA for Afrezza in pediatric patients with PDUFA date of May 29, 2026. MannKind also continues advancing its pipeline including nintedanib DPI with first patient enrollment in the INFLO-1 Phase 1b study completed in December.

Vertex Pharmaceuticals (NASDAQ: VRTX) provided pipeline and business updates ahead of the J.P. Morgan Healthcare Conference, highlighting strong commercial execution and rapid R&D progress setting up continued growth and important milestones for 2026. The company increased estimates for people with CF in all target markets to approximately 112,000 including approximately 97,000 in core markets, while CASGEVY realized greater than $100 million revenue in 2025 reflecting more than 60 patient infusions.

“2025 was a year of strong commercial execution and rapid R&D progress, setting up the company for continued growth and many important milestones in 2026,” said Reshma Kewalramani, M.D., CEO and President of Vertex. “Building on this momentum, we are focused on expanding our commercial reach in multiple disease areas; advancing the emerging renal franchise, including the potential near-term launch of povetacicept; and progressing our mid- and late-stage clinical pipeline.”

Vertex expects to complete the rolling BLA filing for U.S. accelerated approval of povetacicept in IgAN in the first half of 2026 using a priority review voucher to expedite review from ten months to six months. The company also plans to complete enrollment in both Phase 3 studies of suzetrigine in diabetic peripheral neuropathy by end of 2026, with more than 500,000 JOURNAVX prescriptions written and filled in 2025.

Fate Therapeutics (NASDAQ: FATE) presented updated Phase 1 clinical data of FT819 off-the-shelf CAR T-cell product candidate demonstrating meaningful decrease in disease and favorable safety profile with twelve systemic lupus erythematosus patients now treated and first systemic sclerosis patient dosed. The company continues to advance preparations for a pivotal study and is engaged in discussions with the FDA under its RMAT designation regarding plans to initiate registrational trial in 2026.

“We are very pleased with the accelerating patient enrollment, the expansion of U.S. clinical sites, and the addition of international clinical sites, which together are enabling broader access to FT819 for patients suffering with lupus,” said Bob Valamehr, Ph.D., M.B.A., President and CEO of Fate Therapeutics. “The updated FT819 clinical data continue to demonstrate meaningful and durable responses with the use of less-intensive conditioning chemotherapy and a differentiated safety profile.”

Preliminary data in Regimen A showed mean SLEDAI-2K score decreased progressively from baseline with DL1 dropping 50% at month 3 and 70% at month 6, while DL2 decreased 65% at month 3 and 78% at month 6. Clinical SLEDAI-2K of 0 was achieved in 5 out of 10 patients with no Grade >2 CRS, ICANS, or GVHD reported.

Ardelyx (NASDAQ: ARDX) presented real-world evidence studies of XPHOZAH (tenapanor) demonstrating patient satisfaction and reduction in serum phosphate at the American Society of Nephrology’s Kidney Week. The first real-world study showed patients prescribed tenapanor experienced a reduction in serum phosphate of nearly 1 mg/dL on average, with 45.3% experiencing at least 1 mg/dL reduction.

“We are excited to present new data on XPHOZAH at ASN’s Kidney Week, including the first results from our prospective, observational cohort study designed to evaluate the impact of an XPHOZAH-based regimen in a real-world setting,” said Edward Conner, Chief Medical Officer. “Our results show the impact XPHOZAH can have in reducing serum phosphorus levels for these patients.”

Real-world survey data collected through the ArdelyxAssist patient services program showed that 63% of patients reported their phosphate levels were better since starting tenapanor. Among patients who reported a change in serum phosphate levels, 69% indicated their outlook on serum phosphate control was better, with improvements attributed to better control, improved bowel movements, and lower pill burden.

Source:
https://equity-insider.com/2025/03/21/unlocking-the-trillion-dollar-ai-market-what-investors- need-to-know/ 

CONTACT:

Equity Insider


[email protected]


(604) 265-2873

DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Equity Insider is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Avant Technologies Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Avant Technologies Inc. which were purchased in the open market. MIQ reserves the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

SOURCES CITED:

1. https://www.mordorintelligence.com/industry-reports/global-regenerative-medicines-market-industry
2. https://www.fda.gov/news-events/press-announcements/fda-increases-flexibility-requirements-cell-and-gene-therapies-advance-innovation
3. https://www.biospace.com/drug-development/biotech-investors-bet-on-a-2026-rebound-as-deal-activity-accelerates
4. https://www.globenewswire.com/news-release/2026/01/20/3221521/0/en/Biotechnology-Market-Size-to-Surpass-USD-9-06-Trillion-by-2035.html

Logo: https://mma.prnewswire.com/media/2840019/Equity_Insider_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/breaking-barriers-how-2026s-top-clinical-leaders-are-disrupting-chronic-disease-markets-302670105.html